Healthcare Realty Trust Valuation
Is H2TA34 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of H2TA34 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: H2TA34 (R$25.23) is trading above our estimate of fair value (R$22.06)
Significantly Below Fair Value: H2TA34 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for H2TA34?
Key metric: As H2TA34 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is H2TA34's PS Ratio? | |
|---|---|
| PS Ratio | 5.1x |
| Sales | US$1.29b |
| Market Cap | US$6.67b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 9.2x |
| Enterprise Value/EBITDA | 15.1x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does H2TA34's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 10.4x | ||
HGLG11 Cshg Logistica - Fundo De Investimento Imobiliario | 11.9x | n/a | R$5.2b |
CTRE CareTrust REIT | 20.9x | 17.0% | US$5.6b |
SBRA Sabra Health Care REIT | 6.5x | 5.8% | US$4.4b |
AHR American Healthcare REIT | 2.2x | 9.7% | US$4.4b |
H2TA34 Healthcare Realty Trust | 5.1x | 0.08% | R$6.7b |
Price-To-Sales vs Peers: H2TA34 is good value based on its Price-To-Sales Ratio (5.1x) compared to the peer average (10.4x).
Price to Sales Ratio vs Industry
How does H2TA34's PS Ratio compare vs other companies in the Global Health Care REITs Industry?
| 4 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 4 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: H2TA34 is good value based on its Price-To-Sales Ratio (5.1x) compared to the Global Health Care REITs industry average (6.7x).
Price to Sales Ratio vs Fair Ratio
What is H2TA34's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 5.1x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate H2TA34's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Iron Mountain
US$35.4b
Iron Mountain Incorporated (NYSE: IRM) is a global leader in information management services.
I1RM34
US$690.06
7D
1.4%
1Y
123.1%
Cshg Logistica - Fundo De Investimento Imobiliario
R$5.2b
Specializes in real estate investments.
HGLG11
R$154.50
7D
0.2%
1Y
-3.5%
Medical Properties Trust
US$2.7b
A self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities.
M2PW34
US$12.49
7D
0.6%
1Y
8.3%